More options are on the way to treat patients with presbyopia, according to a presentation at Real World Ophthalmology.
Jennifer Loh, MD, said more than 120 million people in the United States have presbyopia, and about 16% of them do not have adequate correction.
“Ten percent of presbyopic patients were willing to trade 5% off their life in order to get rid of their presbyopia,” she said. “That’s obviously a pretty big deal.”
Allergan received FDA approval for Vuity (pilocarpine hydrochloride ophthalmic solution 1.25%) in October 2021, and at least seven other